Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mineralys Therapeutics Inc (MLYS)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 8
  • 0 comments

Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Market reaction Comment Full text

Myomo Inc (MYO)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 19
  • 1 comments

Myomo Reports Third Quarter 2025 Financial and Operating Results

Market reaction Comment Full text

Oculis Holding AG (OCS)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 18
  • 1 comments

Oculis Reports Q3 2025 Financial Results and Provides Company Update

Market reaction Comment Full text

Cardio Diagnostics Holdings Inc (CDIOW)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 13
  • 1 comments

enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial

Market reaction Comment Full text

enGene Inc (ENGNW)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 19
  • 1 comments

enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial

Market reaction Comment Full text

Stereotaxis Inc. (STXS)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 21
  • 1 comments

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Market reaction Comment Full text

Neurocrine Biosciences Inc (NBIX)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 15
  • 1 comments

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder

Market reaction Comment Full text

Avita Medical, Inc. (AVHHL)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 14
  • 1 comments

enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial

Market reaction Comment Full text

ADC Therapeutics SA (ADCT)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 20
  • 1 comments

enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial

Market reaction Comment Full text

Oculis Holding AG (OCS)

  • Business News
  • Nov. 10, 2025, 21:05 UTC
  • 20
  • 1 comments

Oculis birtir uppgjör fyrir þriðja ársfjórðung 2025 og kynnir áfanga í rekstri félagsins

Market reaction Comment Full text
  • Previous
  • 724
  • 725
  • 726
  • 727
  • 728
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2441)
  • SEC News(193597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125898)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin